Workflow
Amneal's generic targeting Jazz Pharma’s Xyrem cleared (AMRX)
Seeking Alpha·2025-09-11 15:56

Core Viewpoint - Amneal Pharmaceuticals received FDA approval for its generic version of Jazz Pharmaceuticals' sleep disorder therapy Xyrem, allowing market entry for the product [2] Company Summary - Amneal Pharmaceuticals' Abbreviated New Drug Application (ANDA) has been approved by the FDA, enabling the launch of its generic product [2]